汇通达网络(09878):年报点评报告:业务结构优化,发展新阶段重回快车道
浙商证券· 2025-04-11 10:47
汇通达网络(09878) 报告日期:2025 年 04 月 11 日 业务结构优化,发展新阶段重回快车道 ——汇通达网络年报点评报告 投资要点 证券研究报告 | 公司点评 | IT 服务Ⅱ 投资评级: 买入(维持) 2024 年服务业务板块业务结构: 门店 SaaS+订阅 5亿(-9%),商家解决方案 1亿 (+8%)。截至 24 年底,公司注册会员零售门店突破 24.9 万家,同增 5%;活跃 会员零售门店达 9.5万家,同增 5%;订阅 SaaS+用户总数近 10.8 万家,其中付费 SaaS+用户超 3.8 万家。 渠道端线上线下两手抓,2024 年新渠道销售额达 36 亿。截至 2024 年底,公司线 下渠道已覆盖全国 21 个省、2.5 万乡镇、24.8 万家会员店。此外进一步布局线 上、社群和海外渠道,试点开展社交电商和内容电商业务,上线社交电商"芸豆 派"商城;私域与社群渠道,推进政采企采,与积分礼品等平台达成战略合作。 此外亦积极试点跨境出海业务,销售阿尔蒂沙空调等产品。 ❑ 迎合时代浪潮,接入 DeepSeek 大模型 公司旗下"千橙云 SaaS+"平台已全面接入 DeepSeek,通过 A ...
京东物流(02618):预计Q1收入再提速,利润稳健增长
申万宏源证券· 2025-04-11 10:12
Investment Rating - The investment rating for the company is maintained as "Buy" [2][6] Core Views - The company is expected to see a revenue acceleration in Q1 2025, with a projected revenue of 46.6 billion RMB and an adjusted net profit of 700 million RMB [6] - The focus of the company is shifting towards revenue growth and investment, with expectations of expansion in express delivery volume, integrated supply chain customer numbers, and overseas layout [6] - The company is anticipated to achieve a net profit margin of 4.3% in 2024, indicating a strong improvement in profitability [6] - The profit forecast has been adjusted downwards, with expected adjusted net profits for 2025-2027 being 83.07 billion, 91.66 billion, and 105.13 billion RMB respectively, reflecting a growth of 4.93%, 10.34%, and 14.70% [6][7] Financial Data and Profit Forecast - Revenue projections for the company are as follows: - 2023: 166,625 million RMB - 2024: 182,838 million RMB - 2025E: 204,215 million RMB - 2026E: 225,948 million RMB - 2027E: 247,880 million RMB - The adjusted net profit forecasts are: - 2023: 2,761 million RMB - 2024: 7,917 million RMB - 2025E: 8,307 million RMB - 2026E: 9,166 million RMB - 2027E: 10,513 million RMB - The earnings per share (EPS) are projected to be: - 2023: 0.44 RMB - 2024: 1.25 RMB - 2025E: 1.31 RMB - 2026E: 1.45 RMB - 2027E: 1.66 RMB - The price-to-earnings (PE) ratio is expected to decrease from 24 in 2023 to 6 in 2027 [3][7]
毛戈平(01318):2024年年报点评:品牌持续破圈,复购率稳步提升
长江证券· 2025-04-11 10:12
丨证券研究报告丨 港股研究丨公司点评丨毛戈平(1318.HK) [Table_Title] 毛戈平 2024 年年报点评:品牌持续破圈,复购 率稳步提升 报告要点 [Table_Summary] 2024 年,公司实现营业收入 38.85 亿元,同比增长 34.6%;归母净利润 8.81 亿元,同比增长 33%;经调整净利润 9.24 亿元,同比增长 39.2%。调整项主要为上市开支 2812 万元和激励费 用 1502 万元。 分析师及联系人 [Table_Author] SAC:S0490514080004 SAC:S0490520080019 SFC:BUV258 李锦 罗祎 曾维朵 请阅读最后评级说明和重要声明 %% %% %% %% research.95579.com 1 毛戈平(1318.HK) cjzqdt11111 [Table_Title 毛戈平 20242]年年报点评:品牌持续破圈,复购 率稳步提升 [Table_Summary2] 事件描述 事件评论 丨证券研究报告丨 2025-04-11 港股研究丨公司点评 [Table_Rank]投资评级 买入丨维持 公司基础数据 [Table_B ...
远大医药(00512):024年归母净利同比增长31%,核药龙头杨帆启航
国信证券· 2025-04-11 09:45
证券研究报告 | 2025年04月11日 远大医药(00512.HK) 优于大市 2024 年归母净利同比增长 31%,核药龙头杨帆启航 收入同比增长 10.6%,归母净利润同比增长 31.3%。2024 年公司实现收入 116.45 亿港币,同比增长 10.6%,扣除汇率变动影响同比增长约 12.8%;实 现归母溢利 24.68 亿港币,同比增长 31.3%;若扣除对 Telix 投资的公允价 值变动收益(7.08 亿港币),正常化归母溢利约 17.61 亿港币,同比增长约 2.5%,进一步扣除汇率变动的影响后同比增长约 4.6%,在较大的外部环境压 力下保持业绩的良好增长。 五官科和呼吸类产品表现亮眼,核药抗肿瘤板块持续高速放量。扣除汇率变 动影响,2024 年制药科技板块实现收入 73.18 亿港币,同比增长 9.6%,其 中呼吸及危重症业务收入 17.09 亿港币,同比增长约 26.9%,主要因为核心 产品切诺的临床需求持续增长以及新产品恩卓润、恩明润和布地奈德鼻喷雾 剂的快速放量;五官科业务收入 27.04 亿港币,同比增长 19.3%,主要是新 品销售带来增长;心脑血管急救业务收入 21.76 亿 ...
医脉通(02192):深度:中国最大医生平台,内容专业,变现成熟,长期高增长
海通国际证券· 2025-04-11 08:43
Investment Rating - The report maintains an "OUTPERFORM" rating for Medlive Technology with a target price of HK$15.00, while the current price is HK$11.60 [2]. Core Insights - Medlive Technology is recognized as China's largest physician platform, providing professional content and mature monetization strategies, with sustained high growth expected [1][3]. - The company has a significant market presence, covering over 4 million registered physicians, which accounts for 88% of the total practicing physicians in China [3][9]. - The revenue forecast for Medlive Technology shows a compound annual growth rate (CAGR) of 30% from 2025 to 2027, with expected revenues of ¥726 million, ¥944 million, and ¥1.227 billion for the respective years [5]. Summary by Sections 1. Medlive Technology Overview - Medlive Technology is a leading digital marketing service platform focused on physicians, with a history dating back to 1996 [9]. - The company primarily serves B2B pharmaceutical and medical device companies, deriving 82% of its revenue from precision marketing and enterprise solutions [12][13]. 2. Industry Analysis - The Chinese medical digital marketing market is expected to grow rapidly, driven by increased online marketing expenditures from pharmaceutical companies, which reached approximately ¥219.7 billion in 2023 [21][26]. - Regulatory changes are pushing pharmaceutical representatives towards academic promotion, enhancing the demand for digital marketing solutions [28][31]. 3. Financial Performance - From 2018 to 2024, Medlive Technology experienced a revenue CAGR of 37.3% and a profit CAGR of 69.0%, with an operating profit margin of 21.2% [3][5]. - The revenue structure is primarily supported by precision marketing and enterprise solutions, which are interrelated and contribute to overall growth [12][13]. 4. Profit Forecast and Valuation - The adjusted net profit for 2025-2027 is projected to be ¥3.2 billion, ¥3.5 billion, and ¥3.9 billion, with growth rates of -1%, 7%, and 13% respectively [5]. - The valuation is based on a P/E ratio of 32x for 2025, leading to a target price of HK$15.00 per share [5]. 5. Governance Structure - The management team is experienced, with key figures having over 10 years in the industry, ensuring a stable governance structure [18][19]. - The shareholding structure is concentrated, with the CEO holding 36.5% of the shares, alongside strategic support from M3, which also holds 36.5% [19][25].
安踏体育(02020):运营表现超预期,收购狼爪户外布局再添一棋
申万宏源证券· 2025-04-11 08:15
Investment Rating - The investment rating for Anta Sports is "Buy" (maintained) [2] Core Views - The company reported better-than-expected retail performance for Q1 2025, with overall revenue growth in double digits, particularly strong growth from Anta and FILA brands [7] - The acquisition of Jack Wolfskin for $290 million enhances Anta's multi-brand strategy and global presence in the outdoor apparel market [7] - The company maintains a healthy inventory level with a slight increase in discount rates, indicating stable demand [7] - The financial forecasts for net profit are projected at RMB 134.1 billion, RMB 147.0 billion, and RMB 160.1 billion for 2025, 2026, and 2027 respectively, with corresponding PE ratios of 16, 14, and 13 [7] Financial Data and Earnings Forecast - Revenue projections are as follows: - FY2023: RMB 623.6 billion - FY2024: RMB 708.3 billion - FY2025E: RMB 779.5 billion - FY2026E: RMB 839.2 billion - FY2027E: RMB 900.7 billion - Year-on-year growth rates for revenue are expected to be 16%, 14%, 10%, 8%, and 7% respectively [6] - Net profit forecasts are as follows: - FY2023: RMB 102.4 billion - FY2024: RMB 156.0 billion - FY2025E: RMB 134.1 billion - FY2026E: RMB 147.0 billion - FY2027E: RMB 160.1 billion - Year-on-year growth rates for net profit are expected to be 35%, 52%, -14%, 10%, and 9% respectively [6] - The gross margin is projected to be around 62% for the next few years, with slight fluctuations [6]
吉利汽车(00175):业绩预告点评:2025Q1业绩超预期,新品周期即将开启
华西证券· 2025-04-11 06:43
Investment Rating - The investment rating for Geely Automobile is "Buy" [1] Core Views - Geely Automobile's Q1 2025 performance exceeded expectations, with a significant increase in profits driven by a strong new energy vehicle (NEV) sales momentum and an upcoming product cycle [2][3][4] - The company is expected to launch 10 new NEV models in 2025, aiming for a total NEV sales target of 1.5 million units [3] - The merger of Zeekr and Lynk & Co is anticipated to enhance Geely's competitiveness in the mid-to-high-end vehicle market through a focus on smart technology [4][5] - Geely is transitioning into a smart technology company, with a robust technological ecosystem supported by its advanced driving solutions and computing power [5] Financial Summary - The company forecasts a Q1 2025 net profit of RMB 5.2-5.8 billion, representing a year-on-year growth of 220-270% [2] - Revenue projections for 2025-2027 are set at RMB 317.96 billion, RMB 392.94 billion, and RMB 468.08 billion, respectively, with net profits of RMB 14.04 billion, RMB 17.92 billion, and RMB 23.04 billion [7][9] - The expected earnings per share (EPS) for 2025-2027 are RMB 1.39, RMB 1.78, and RMB 2.29, respectively [7][9] - The price-to-earnings (PE) ratios for 2025-2027 are projected to be 9.90, 7.76, and 6.03 times [7][9]
安踏体育(02020):25Q1线上折扣加深,收购狼爪完善户外品牌矩阵
招商证券· 2025-04-11 06:35
Investment Rating - The report maintains a strong buy rating for Anta Sports [3][10] Core Views - In Q1 2025, Anta's main brand and FILA both experienced high single-digit growth, while other brands saw growth between 65% and 70%. The company is deepening online discounts and has a relatively healthy inventory situation [1][2][10] - Anta plans to acquire Jack Wolfskin for $290 million to enhance its outdoor brand portfolio, which is expected to be completed by the end of Q2 or early Q3 2025 [6][10] - The projected net profits for Anta from 2025 to 2027 are estimated at 13.43 billion, 15.51 billion, and 17.15 billion yuan, with year-on-year growth rates of -14%, 15%, and 11% respectively, excluding one-time gains from the Amer acquisition [1][10] Financial Data and Valuation - Total revenue for 2025 is projected to be 77.96 billion yuan, with a year-on-year growth rate of 10%. The company expects to achieve revenues of 85.45 billion yuan in 2026 and 92.97 billion yuan in 2027 [8][10] - The current market capitalization corresponds to a PE ratio of 16x for 2025 and 14x for 2026 [10] - As of the end of Q1 2025, Anta's inventory turnover ratio is less than 5, indicating effective inventory management [6][10] Brand Performance - Anta's main brand saw high single-digit growth in Q1 2025, with children's products also performing well. The overall online sales for the brand experienced low double-digit growth [1][11] - FILA's sales in Q1 2025 showed high single-digit growth, with children's products growing at a low double-digit rate and the FILA Fusion line achieving high double-digit growth [2][11] - Other brands under Anta, such as Descente and KOLON, reported significant growth rates of 60% and 100% respectively in Q1 2025 [2][11]
猫眼娱乐(01896):公司业绩受电影大盘疲软影响,市场覆盖率及核心竞争力有望持续提升
长江证券· 2025-04-11 05:43
Investment Rating - The investment rating for the company is "Buy" and it is maintained [8] Core Viewpoints - The company's performance in 2024 was impacted by a weak film market, with total revenue of 4.082 billion yuan, a year-on-year decrease of 14.19%. The entertainment content service accounted for 48% of total revenue, online entertainment ticketing services 47.1%, and advertising services and others 4.9%. The net profit attributable to shareholders was 182 million yuan, down 80.02% year-on-year, while adjusted net profit was 310 million yuan, a decrease of 69.9% [2][5] Revenue Breakdown - Entertainment content services generated 1.96 billion yuan in 2024, a year-on-year decrease of 14.8%, primarily due to underperforming box office results of certain films. Online entertainment ticketing services brought in 1.922 billion yuan, down 14.9% year-on-year, attributed to a decline in the total box office of the Chinese film market. Advertising services and other revenues increased by 1.2% to 201 million yuan [9] Market Coverage and Competitive Strength - The company achieved record highs in both the number of films participated in and market coverage, with 63 domestic films released in 2024, including 36 films under its control, generating a total box office of 23.2 billion yuan. The company participated in 8 of the top 10 domestic films by box office in 2024 [9] Future Prospects - The company is optimistic about its content pipeline for 2025, with several films scheduled for release, including the first 3D animation "Time's Son" on May 30, and other animated films and projects in development. The live performance market is also showing strong demand, with the company providing ticketing services for both domestic and international artists [9] Technological Advancements - The company is continuously updating its "Cat Eye Professional Version" and "Cat Eye Research Institute," exploring more collaboration scenarios in "AI + Film." The "Cat Eye Professional Version" covers major global markets, providing domestic users with insights into overseas markets, while the "Cat Eye Research Institute" offers in-depth data services for films [9]
吉利汽车(00175):25Q1业绩超预期,规模效应驱动盈利改善
民生证券· 2025-04-11 05:33
吉利汽车(0175.HK)系列点评二十四 25Q1 业绩超预期 规模效应驱动盈利改善 2025 年 04 月 11 日 ➢ 事件概述:4 月 10 日,公司发布了"会计政策变更"和"正面盈利预告" 两个公告: 1)"会计政策变更"公告: 0175 就共同控制下实体企业合并的会计政策变更为 合并实体的资产负债按控股方的现有账面值列账。就 2025 年 2 月 14 日极氪与 领克完成的战略整合公告所述的未审计收益人民币 64.7 亿元,在本次会计政策 变更后将不再形成。其余详细的追溯财务调整将会在季报披露。 2)"正面盈利预告"公告:在上述变更后,0175 预计其 2025 年 1 季度的归母利 润为人民币 52-58 亿元,同比增长 220-270%,其中汇兑税后净收益占人民币 20-23 亿元。1 季度的销量增长及新能源业务持续改善带动盈利增长。 ➢ Q1 业绩超预期 规模化提振盈利。2025Q1,公司乘用车累计销量 70.4 万 辆,同比+47.9%;新能源累计 33.9 万辆,同比+135.4%。出口方面,2025Q1 海外销量 8.9 万辆,同比+2.0%,环比-1.3%。按中值计算,2025Q1 归 ...